The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Versant Capital Management Inc

Versant Capital Management Inc boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 306.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 988 shares of the medical device company’s stock after purchasing an additional 745 shares during the period. Versant Capital Management Inc’s holdings in Cooper Companies were worth $91,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Ashton Thomas Securities LLC acquired a new position in Cooper Companies in the third quarter valued at $25,000. Covestor Ltd increased its stake in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after acquiring an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. raised its holdings in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after purchasing an additional 275 shares during the period. Friedenthal Financial acquired a new position in shares of Cooper Companies in the 3rd quarter valued at about $50,000. Finally, Cromwell Holdings LLC purchased a new stake in shares of Cooper Companies during the 3rd quarter worth about $52,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on COO. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Citigroup decreased their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Morgan Stanley decreased their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Finally, Wells Fargo & Company raised their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Stock Up 1.2 %

Shares of NASDAQ:COO opened at $91.79 on Friday. The firm has a market cap of $18.32 billion, a PE ratio of 47.07, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The company has a fifty day simple moving average of $99.16 and a 200 day simple moving average of $98.80. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the previous year, the firm earned $0.87 EPS. The company’s revenue was up 9.8% on a year-over-year basis. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.